REQUEST A DEMO
Total
USD $0.00
Search more companies

Instytut Ekspertyz Toksykologicznych Sp. z o.o. (Poland)

Main Activities: Scientific Research and Development Services
Secondary Activities: Research and Development in Biotechnology (except Nanobiotechnology) | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Instytut Ekspertyz Toksykologicznych Sp. z o.o. Profile Updated: June 17, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Instytut Ekspertyz Toksykologicznych Sp. z o.o is a medical diagnostics company specializing in research and development of an innovative platform for diagnosing addiction and toxicology. The company offers Catynon derivatives, synthetic cannabinoids, and the diagnostic platform "COMBITOX" for patients addicted to alcohol, drugs, medications, and at risk of addiction.

Headquarters
Ul. Marii Curie-Sklodowskiej 55/61/306
Wroclaw; Dolnoslaskie; Postal Code: 50-369

Contact Details: Purchase the Instytut Ekspertyz Toksykologicznych Sp. z o.o. report to view the information.

Website: http://www.iet.wroc.pl

Basic Information
Registered Capital:
Purchase the Instytut Ekspertyz Toksykologicznych Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Instytut Ekspertyz Toksykologicznych Sp. z o.o. report to view the information.
Incorporation Date:
March 02, 2017
Key Executives
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Instytut Ekspertyz Toksykologicznych Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
1.26%
Total operating revenue
1.26%
Operating profit (EBIT)
-101.19%
EBITDA
-98.98%
Net Profit (Loss) for the Period
-100.51%
Total Assets
-17.06%
Total Equity
-64.33%
Operating Profit Margin (ROS)
-13.04%
Net Profit Margin
-12.99%
Return on Equity (ROE)
-148.27%
Debt/Equity
31.78%
Quick Ratio
-1.58%
Cash Ratio
-0.41%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?